当前位置: 首页 > 期刊 > 《新医学》 > 20198
编号:13539695
新诊断2型糖尿病合并非酒精性脂肪性肝病血清铁调素水平的变化及其意义 ?(5)
http://www.100md.com 2019年8月1日 《新医学》 20198
     [20] Utzschneider KM, Largajolli A, Bertoldo A, Marcovina S, Nelson JE, Yeh MM, Kowdley KV, Kahn SE. Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women. J Diabetes Complications,2014,28(2):177-184.

    [21] Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol,2016,8(4):211-225.

    [22] Arredondo M, Fuentes M, Jorquera D, Candia V, Carrasco E, Leiva E, Mujica V, Hertrampf E, Pérez F. Cross-talk between body iron stores and diabetes: iron stores are associated with activity and microsatellite polymorphism of the heme oxygenase and type 2 diabetes. Biol Trace Elem Res,2011,143(2):625-636.

    [23] 孙雪,张亚华,徐淑静,时立新,彭年春,张巧. 初发2型糖尿病患者内脂素与铁代谢关系研究. 重庆医学,2015,44(2):194-196.

    [24] Boga S, Alkim H, Alkim C, Koksal AR, Bayram M, Yilmaz Ozguven MB, Tekin Neijmann S. The relationship of serum hem-ojuvelin and hepcidin levels with iron overload in nonalcoholic fatty liver disease. J Gastrointestin Liver Dis,2015,24(3):293-300.

    [25] Fu YQ, Yang H, Zheng JS, Zeng XY, Zeng W, Fan ZF, Chen M, Wang L, Li D. Positive association between metabolic syndrome and serum uric acid in Wuhan. Asia Pac J Clin Nutr,2017,26(2):343-350.

    [26] 李晓敏,陈泽娜,古洁若. 高尿酸血症的现状不容忽视. 新医学, 2016, 47(3):137-141.

    [27] Araújo Sampaio F, Monte Feitosa M, Hermes Sales C, Costa e Silva DM, Clímaco Cruz KJ, Oliveira FE, Colli C, do Nasci-mento Marreiro D. Influence of magnesium on biochemical parameters of iron and oxidative stress in patients with type 2 diabetes. Nutr Hosp,2014,30(3):570-576.

    (收稿日期:2019-01-16)

    (本文編辑:林燕薇), http://www.100md.com(孙艳 陈智伟 张华清 代丹娇 王小庆)
上一页1 2 3 4 5